Logo.png
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
19 mai 2022 08h30 HE | Vyant Bio, Inc.
Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights
16 mai 2022 08h30 HE | Vyant Bio, Inc.
Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights  ●Progress in the discovery of small molecule therapeutics to treat neurodevelopmental and...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
10 mai 2022 16h01 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
05 mai 2022 16h30 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
30 mars 2022 07h50 HE | Vyant Bio, Inc.
Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative...
Logo.png
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
29 mars 2022 17h00 HE | Vyant Bio, Inc.
Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021
28 mars 2022 16h30 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Issues Letter to Shareholders
01 mars 2022 08h30 HE | Vyant Bio, Inc.
Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company focused on identifying unique biological...
Logo.png
Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
10 janv. 2022 08h00 HE | Vyant Bio, Inc.
Cherry Hill, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio to Present at The Benchmark Company Discovery One-on-One Investor Conference
29 nov. 2021 09h15 HE | Vyant Bio, Inc.
Cherry Hill, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...